- Launch of two natural actives CapilAcid™ for haircare and Oleobiota™ for skincare applications
- Meeting the demand for sustainable, scientifically substantiated beauty and personal care products
- Boosting its biosolutions portfolio
Evonik has launched two new products to meet the demands for sustainable, natural actives in the beauty and personal care markets. The two newly launched products are CapilAcid™, an active ingredient derived from the Maqui fruit which is a comprehensive protector and powerful antioxidant for the hair, and Oleobiota™, an active ingredient sourced sustainably from the Misiones rainforest for sebum-normalizing skin care. Both products originate from the company Novachem, which was acquired by Evonik one year ago and is being integrated into the company’s Care Solutions business.
As part of Evonik’s life sciences division Nutrition & Care, the Botanicals & Natural Actives segment is playing an important role in expanding the company’s portfolio of biosolutions. The value Evonik brings is the ability to translate the phytochemical profile of plants into skin and hair care benefits. In doing so, Evonik enables customers to meet the demands for sustainable, scientifically substantiated beauty and personal care products.
“Our latest product launches are a testament to our collaborative spirit. Novachem has enabled us to elevate our offerings, and deliver even more unique sustainable solutions to our customers,” said Ute Schick, head of the Care Solutions business line at Evonik.
Novachem is Evonik’s most recent acquisition and strengthens Evonik’s portfolio of botanicals and natural active ingredients for skin and hair applications. These support circular beauty – a concept that preserves natural resources while promoting beauty and wellbeing.
Within its Care Solutions business line, Evonik offers a strong portfolio of active ingredients and delivery systems that offer significant opportunities to innovate new cosmetic ingredients with scientifically proven claims, allowing customers to stand out in the market. Evonik is transforming its Care Solutions business line into the preferred sustainable specialties partner for the personal care industry. This transformation enhances the entire portfolio, creates new common solutions, opens new markets, accelerates growth, and creates significant value.
More about the new products:
CapilAcid™ is an active ingredient derived from the Maqui fruit, which grows exclusively in Andean Patagonia. CapilAcid™ serves as a comprehensive protector from the root to the tip of the hair and is a powerful antioxidant. It excels in acidic formulations, safeguarding hair against exposome-induced stress and promoting overall hair health.
Oleobiota™ is an active ingredient from the Misiones rainforest used for regulating oiliness and mattifying combination and oily skin, while minimizing the appearance of pores. Derived from sustainably cultivated Ñangapirí leaves, Oleobiota™ also supports the health of the Misiones rainforest as it was developed in accordance with the Nagoya Protocol that builds on and supports the implementation of the Convention on Biological Diversity.
More information about Botanicals & Natural Actives at Evonik
Company information
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15.3 billion and an operating profit (adjusted EBITDA) of €1.66 billion in 2023. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. More than 33,000 employees work together for a common purpose: We want to improve life today and tomorrow.
About Nutrition & Care
The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €3.61 billion in 2023 with more than 5,600 employees.
Disclaimer
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.